We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · October 24, 2019

Circulating Tumor DNA Analyses as Prognostic Markers for Stage III Colon Cancer

JAMA Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
JAMA Oncol 2019 Oct 17;[EPub Ahead of Print], J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee, R Wong, S Kosmider, S Ananda, J McKendrick, B Lee, JH Cho, I Faragher, IT Jones, J Ptak, MJ Schaeffer, N Silliman, L Dobbyn, L Li, C Tomasetti, N Papadopoulos, KW Kinzler, B Vogelstein, P Gibbs

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading